Alere Inc.

Alere Inc., now operating under Abbott, specializes in point-of-care diagnostics, providing rapid testing solutions for healthcare professionals. The company focuses on delivering lab-accurate results quickly to support healthcare decisions, enhance patient safety, and improve clinical outcomes worldwide. Alere is recognized for its leadership in rapid testing for various health metrics, including lipids and glucose. Key products include the Cholestech LDX Analyzer, which offers a complete lipid profile and glucose results in just five minutes, and the Afinion HbA1c test for monitoring diabetes control. Alere also provides eScreen, a next-generation technology for employee drug screening, which streamlines compliance and reduces costs for employers. The company emphasizes the impact of point-of-care testing on medical outcomes and its role in addressing diverse diagnostic needs.